Actively Recruiting
Shanghai Epidemiology Study for Adolescents and Children with Cancer
Led by Children's Cancer Group, China · Updated on 2025-02-13
2000
Participants Needed
2
Research Sites
665 weeks
Total Duration
On this page
Sponsors
C
Children's Cancer Group, China
Lead Sponsor
S
Shanghai Children's Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to describe the rates of illness, death, disability, and survival among children and adolescents diagnosed with cancer in Shanghai since January 2002. The study includes a wide range of malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, various lymphomas, central nervous system tumors, Neuroblastoma, and Wilms tumor. The goal is to better understand how these cancers affect young patients over time. The study collects detailed information about each patient's diagnosis and personal details, including name, gender, date of birth, diagnosis date, cancer type, residence, and survival status at last follow-up. Data is gathered for all eligible patients diagnosed since 2002, without any treatments or interventions being tested. Participants' information is analyzed to measure outcomes such as overall survival and mortality over a five-year period. The study tracks patients' health status and survival, excluding those lost to follow-up or who died from unrelated accidents. This observation continues until January 2030, providing a long-term view of cancer outcomes in this group.
CONDITIONS
Brief Title
Shanghai Epidemiology Study for Adolescents and Children with Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children and adolescents aged 0 to 19 years
- Diagnosed with cancer in Shanghai since January 2002
You will not qualify if you...
- Patients lost to follow-up
- Death caused by accidents or other non-cancer related reasons such as car accidents or falls from great height
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants who were diagnosed with cancer since January 2002 are observed to collect information on morbidity, mortality, disability, and survival rates.
Data collected from medical records and follow-up contacts
Trial Site Locations
Total: 2 locations
1
Shanghai Children's Medical Center
Shanghai, Shanghai Municipality, China, 200127
Active, Not Recruiting
2
Shanghai Municipal Center of Disease Prevention & Control
Shanghai, Shanghai Municipality, China, 200336
Actively Recruiting
Research Team
Y
Yi-Jin Gao, MD
X
Xing-Wei Wang, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here